O Abe

3.1k total citations
45 papers, 736 citations indexed

About

O Abe is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, O Abe has authored 45 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in O Abe's work include Estrogen and related hormone effects (12 papers), Gastric Cancer Management and Outcomes (6 papers) and Metastasis and carcinoma case studies (4 papers). O Abe is often cited by papers focused on Estrogen and related hormone effects (12 papers), Gastric Cancer Management and Outcomes (6 papers) and Metastasis and carcinoma case studies (4 papers). O Abe collaborates with scholars based in Japan, United Kingdom and United States. O Abe's co-authors include R. T. Chlebowski, Matthew L. Baum, I. Craig Henderson, Kasper Langebjerg Andersen, Martin D. Abeloff, G. Bonadonna, J. Cuzick, Rosalin Cooper, Aman U. Buzdar and Paul P. Carbone and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biomedicine & Pharmacotherapy and The Breast.

In The Last Decade

O Abe

45 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Abe Japan 9 336 270 258 120 93 45 736
Celia J. Menendez‐Botet United States 15 472 1.4× 349 1.3× 448 1.7× 161 1.3× 58 0.6× 25 953
M. Camille Alexander United States 6 236 0.7× 164 0.6× 145 0.6× 185 1.5× 54 0.6× 7 586
Paula Pitt Australia 13 344 1.0× 198 0.7× 432 1.7× 108 0.9× 192 2.1× 27 740
Rosalin Cooper United Kingdom 10 499 1.5× 292 1.1× 221 0.9× 174 1.4× 104 1.1× 24 951
Erin L. Walls United States 6 401 1.2× 213 0.8× 473 1.8× 150 1.3× 89 1.0× 7 751
George C. Escher United States 12 302 0.9× 231 0.9× 240 0.9× 189 1.6× 82 0.9× 20 796
Edwin D. Savlov United States 16 363 1.1× 307 1.1× 356 1.4× 186 1.6× 136 1.5× 32 968
DG Hoel United States 6 372 1.1× 142 0.5× 191 0.7× 78 0.7× 112 1.2× 10 624
S. E. Hankinson United States 7 471 1.4× 265 1.0× 263 1.0× 127 1.1× 158 1.7× 14 864
Kohji Enomoto Japan 12 360 1.1× 256 0.9× 121 0.5× 227 1.9× 46 0.5× 26 718

Countries citing papers authored by O Abe

Since Specialization
Citations

This map shows the geographic impact of O Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Abe more than expected).

Fields of papers citing papers by O Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Abe. The network helps show where O Abe may publish in the future.

Co-authorship network of co-authors of O Abe

This figure shows the co-authorship network connecting the top 25 collaborators of O Abe. A scholar is included among the top collaborators of O Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Abe. O Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abe, O, et al.. (2024). Admission Screening Mechanism, Eliminating Distance Obstacles. 1–5. 1 indexed citations
3.
Kimura, Hirokazu, Hisanori Minakami, O Abe, et al.. (1997). Release of superoxide anion from polymorphonuclear leukocytes stimulated by rubella viral antigen-antibody complex in vitro.. PubMed. 41(6). 329–32. 1 indexed citations
4.
Wakai, Kenji, Taro Nakajima, Kenya Kanazawa, et al.. (1995). Epidemiological Study of Tsutsugamushi Disease in Gunma Prefecture A Special Field Study and Serotype. Kansenshogaku zasshi. 69(10). 1118–1125. 2 indexed citations
5.
Abe, O, Kiyoshi Yoshino, Keiji Kimura, et al.. (1994). [Early phase II study of FUT-187 (sepimostat mesilate) on reflux esophagitis--mainly on postgastrectomy reflux esophagitis].. PubMed. 21(6). 845–52. 1 indexed citations
6.
Okazaki, Isao, S. Matsuyama, Fumihiko Suzuki, et al.. (1992). Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screening.. PubMed. 120(6). 908–20. 9 indexed citations
7.
Ueda, Mitsuharu, et al.. (1992). Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor.. PubMed. 11(6). 1951–6. 7 indexed citations
8.
Yoshino, Koichiro, Hiroki Matsui, Ayako Shimada, et al.. (1991). [Modified operation for an early stage gastric cancer].. PubMed. 18(6). 939–44. 3 indexed citations
9.
Abe, O, Keiichi Fujiwara, Yuichi Iino, et al.. (1990). [Phase I study of FK 435].. PubMed. 36(8). 903–13. 3 indexed citations
11.
Nomura, Yoshiaki, O Abe, M Izuo, et al.. (1988). [Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].. PubMed. 15(6). 1863–71. 1 indexed citations
12.
Ishii, Masaru, Tomonori Kato, Norio Sawabu, et al.. (1988). [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].. PubMed. 15(7). 2107–13. 3 indexed citations
13.
Takami, Hideki, et al.. (1987). [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract].. PubMed. 14(2). 495–501. 1 indexed citations
14.
Inada, Tomohiro, et al.. (1985). [Cell kinetics of human lung small cell carcinomas transplanted into nude mice].. PubMed. 12(9). 1775–81. 1 indexed citations
15.
Hattori, Takao, Ken Inoue, Tetsuya Taguchi, et al.. (1985). [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].. PubMed. 12(3 Pt 1). 1850–22. 6 indexed citations
16.
Noguchi, Ryuichi, et al.. (1983). [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients].. PubMed. 10(9). 2000–6. 16 indexed citations
17.
Abe, O, M Izuo, Koji Enomoto, et al.. (1982). [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].. PubMed. 9(5). 866–73. 5 indexed citations
18.
Yoshino, Kenji, Shirô Nakamura, Shigeki Matsumoto, et al.. (1979). EVALUATION OF SPLENECTOMY FOR GASTRIC CARCINOMA. The Japanese Journal of Gastroenterological Surgery. 12(12). 944–949. 12 indexed citations
19.
Wang, D.Y., J.L. Hayward, R.D. Bulbrook, et al.. (1976). Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women. European Journal of Cancer (1965). 12(12). 951–958. 27 indexed citations
20.
Bulbrook, R.D., D.Y. Wang, J.L. Hayward, et al.. (1976). Breast cancer in Britain and Japan: Plasma oestradiol-17β, oestrone and progesterone, and their urinary metabolites in normal British and Japanese women. European Journal of Cancer (1965). 12(9). 725–735. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026